B. Brassart, C. Douarre, M.-F. O’Donohue, V. E. Khoury,
K. Shin-ya, H. Morjani, C. Trantesaux and J. F. Riou, J. Biol.
Chem., 2006, 281, 38721.
4 For recent reviews, see: (a) T. Ou, Y. Lu, J. Tan, Z. Huang,
K.-Y. Wong and L. Gu, ChemMedChem, 2008, 3, 690;
(b) M. Franceschin, Eur. J. Org. Chem., 2009, 2225.
5 K. Shin-ya, K. Wierzba, K. Matsuo, T. Ohtani, Y. Yamada,
K. Furihata, Y. Hayakawa and H. Seto, J. Am. Chem. Soc.,
2001, 123, 1262.
6 (a) T. Doi, M. Yoshida, K. Shin-ya and T. Takahashi, Org. Lett.,
2006, 8, 4165; (b) P. Shirude, E. Gillies, S. Ladame, F. Godde,
K. Shin-Ya, I. Huc and S. Balasubramanian, J. Am. Chem. Soc.,
2007, 129, 11890.
7 (a) F. Rosu, V. Gabelica, K. Shin-yaand and E. D. Pauw, Chem.
Commun., 2003, 2702; (b) E. M. Rezler, J. Seenisamy, S. Bashyam,
M.-Y. Kim, E. White, W. D. Wilson and L. H. Hurley, J. Am.
Chem. Soc., 2005, 127, 9439.
8 M.-Y. Kim, H. Vankayalapati, K. Shin-ya, K. Wierzba and
L. H. Hurley, J. Am. Chem. Soc., 2002, 124, 2098.
9 (a) M. Tera, Y. Sohtome, H. Ishizuka, T. Doi, M. Takagi,
K. Shin-ya and K. Nagasawa, Heterocycles, 2006, 69, 505;
(b) M. Tera, H. Ishizuka, M. Takagi, M. Suganuma, K. Shin-ya
and K. Nagasawa, Angew. Chem., 2008, 120, 5639; M. Tera,
H. Ishizuka, M. Takagi, M. Suganuma, K. Shin-ya and
K. Nagasawa, Angew. Chem., Int. Ed., 2008, 47, 5557;
(c) M. Tera, K. Iida, H. Ishizuka, M. Takagi, M. Suganuma,
T. Doi K. Shin-ya and K. Nagasawa, ChemBioChem, 2009, 10,
431.
10 The interaction of L2H2-6OTD (2), which we have recently
developed, with telomeric G-quadruplex involves two molecules
of L2H2-6OTD (2) per quadruplex9b
.
11 J. Dai, M. Carver, C. Punchihewa, R. A. Jones and D. Yang,
Nucleic Acids Res., 2007, 35, 4927.
12 N. B. Dyatkina, C. D. Roberts, J. D. Keicher, Y. Dai,
J. P. Nadherny, W. Zhang, U. Schmitz, A. Kongpachith,
K. Fung, A. A. Novikov, L. Lou, M. Velligan, A. A. Khorlin
and M. S. Chen, J. Med. Chem., 2002, 45, 805.
13 (a) A. De Cian, L. Guittat, M. Kaiser, B. Sacca, S. Amrane,
A. Bourdoncle, P. Alberti, M. P. Teulade-Fichou, L. Lacroix and
J. L. Mergny, Methods, 2007, 42, 183; (b) J. L. Mergny and
J.-C. Maurizot, ChemBioChem, 2001, 2, 124.
Fig. 3 ESI mass spectra of 10 mM ss-telo24 with 40 mM ligand 3 (A)
or 10 (B).
Research Fellowship for Young Scientists and a grant under
the education program ‘‘Human Resource Development
Program for Scientific Powerhouse’’ provided through TUAT.
14 The oligonucleotide sequences are as follows:
Notes and references
1 For a recent review, see: L. Oganesian and T. M. Bryan, BioEssays,
2007, 29, 155.
2 For recent reviews, see: (a) S. Neidle and G. N. Parkinson,
Biochimie, 2008, 90, 1184. In the presence of K+, telomeric
G-quadruplexes form parallel or antiparallel/parallel mixed-type
structures; see: (b) G. N. Parkinson, M. P. Lee and S. Neidle,
Nature, 2002, 417, 876; (c) D. J. Patel, A. T. Phan and V. Kuryavyi,
Nucleic Acids Res., 2007, 35, 7429; (d) Y. Xu, Y. Noguchi and
H. Sugiyama, Bioorg. Med. Chem., 2006, 14, 5584; (e) A. Ambrus,
D. Cheng, J. Dai, T. Bialis, R. A. Jones and D. Yang, Nucleic Acids
Res., 2006, 34, 2723; (f) J. Dai, C. Punchihewa, A. Ambrus,
D. Chen, R. A. Jones and D. Yang, Nucleic Acids Res., 2007, 35,
2440. In the presence of Na+, telomeric G-quadruplexes adopt an
antiparallel structure; see: (g) Y. Wang and D. J. Patel, Structure,
1993, 1, 263. For folding models of telomeric DNA, see:
(h) R. D. Gray and J. B. Chaires, Nucleic Acids Res., 2008, 36,
4191.
15 W. C. Drewe and S. Neidle, Chem. Commun., 2008, 5295.
16 T. Lemarteleur, D. Gomez, R. Paterski, E. Mandine, P. Mailliet
and J.-F. Riou, Biochem. Biophys. Res. Commun., 2004, 323, 802.
17 The 6OTD dimers 9 and 11 showed PCR-inhibitory activity with
IC50 values of 23.3 Æ 3.7 mM and 35.1 Æ 3.8 mM for telo24 and
41000 mM against ss-telo24-mut, respectively.
18 (a) F. Rosu, V. Gabelica, C. Houssier, P. Colson and E. De Pauw,
Rapid Commun. Mass Spectrom., 2002, 16, 1729; (b) H. Li, Y. Liu,
S. Lin and G. Yuan, Chem.–Eur. J., 2009, 15, 2445.
19 Both 1 : 1 and 3 : 1 stoichiometric complexes of 3 and ss-telo24
were also detected as minor peaks.
20 In the case of 9 and 11, 1 : 1 complexes with DNA were also
observed (as a major peak for dimer 9), although complexations
are thought to be different from the case of 10 (see Fig. S4 and S5
in ESIw).
3 (a) H. Tahara, K. Shin-ya, H. Seimiya, H. Yamada, T. Tsuruo and
T. Ide, Oncogene, 2006, 25, 1955; (b) D. Gomez, T. Wenner,
ꢀc
This journal is The Royal Society of Chemistry 2009
Chem. Commun., 2009, 6481–6483 | 6483